MAPT and tauopathy: Finally, acute treatment of the tauopathy mice with a tau monoclonal antibody partially restored the decreased neuronal activity but did not alter network activity, and the antibody decreased soluble phosphorylated tau (p‐tau), increased insoluble total tau, and attenuated gliosis in the mice.